Adicet Bio (ACET) Operating Income (2017 - 2026)
Adicet Bio (ACET) posted quarterly Operating Income of -$21.6 million for Q1 2026, up 27.82% year-over-year from -$16.9 million in Q1 2025, and up 32.35% quarter-over-quarter from -$31.9 million in Q4 2025.
Adicet Bio (ACET) Operating Income (2017 - 2026) Analysis & Trends
Adicet Bio's Operating Income history runs 10 years deep, the most recent figure standing at -$21.6 million for Q1 2026.
- In Q1 2026, Operating Income rose 27.82% year-over-year to -$21.6 million; the TTM figure through Mar 2026 stood at -$113.8 million (up 10.13% YoY), while the FY2025 annual figure was -$122.1 million, up 4.31% from the prior year.
- Operating Income for Q1 2026 stood at -$21.6 million, up from -$31.9 million in the prior quarter.
- The five-year high for Operating Income was $4.7 million in Q1 2022, with the low at -$52.3 million in Q3 2023.
- The 5-year median for Operating Income is -$31.6 million (2022), against an average of -$29.2 million.
- The sharpest annual moves came in 2022 and 2023: Operating Income soared 122.04% in 2022, then sank 808.07% in 2023.
- Adicet Bio's Operating Income stood at -$31.6 million in 2022, then slipped by 0.0% to -$31.6 million in 2023, then gained by 2.61% to -$30.7 million in 2024, then slipped by 3.72% to -$31.9 million in 2025, then jumped by 32.35% to -$21.6 million in 2026.
- Business Quant data shows ACET's Operating Income at -$21.6 million in Q1 2026, -$31.9 million in Q4 2025, and -$28.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | -22.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.30 Mn |
| Mar 31, 2026 | -21.57 Mn |
| Dec 31, 2025 | -31.89 Mn |
| Sep 30, 2025 | -27.95 Mn |
| Jun 30, 2025 | -32.39 Mn |
| Mar 31, 2025 | -29.89 Mn |
| Dec 31, 2024 | -30.74 Mn |
| Sep 30, 2024 | -33.15 Mn |
| Jun 30, 2024 | -32.85 Mn |
| Mar 31, 2024 | -30.87 Mn |
| Dec 31, 2023 | -31.57 Mn |
| Sep 30, 2023 | -52.26 Mn |
| Jun 30, 2023 | -34.89 Mn |
| Mar 31, 2023 | -33.32 Mn |
| Dec 31, 2022 | -31.57 Mn |
| Sep 30, 2022 | -22.99 Mn |
| Jun 30, 2022 | -22.71 Mn |
| Mar 31, 2022 | 4.71 Mn |
| Dec 31, 2021 | -15.54 Mn |
| Sep 30, 2021 | -13.71 Mn |